Search Page

1

Cite

Share

Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.

Polivka J Jr, Janku F. Polivka J Jr, et al. Pharmacol Ther. 2014 May;142(2):164-75. doi: 10.1016/j.pharmthera.2013.12.004. Epub 2013 Dec 9. Pharmacol Ther. 2014. PMID: 24333502 Review.

Cite

Share

2

Cite

Share

Current status of biomarker research in neurology.

Polivka J, Polivka J Jr, Krakorova K, Peterka M, Topolcan O. Polivka J, et al. Among authors: polivka j jr. EPMA J. 2016 Jul 4;7(1):14. doi: 10.1186/s13167-016-0063-5. eCollection 2016. EPMA J. 2016. PMID: 27379174 Free PMC article. Review.

Cite

Share

3

Cite

Share

[Vitamin D and neurological diseases].

Polívka J, Polívka J Jr, Peterka M, Rohan V, Sevčík P, Topolčan O. Polívka J, et al. Among authors: polivka j jr. Vnitr Lek. 2012 May;58(5):393-5. Vnitr Lek. 2012. PMID: 22716177 Review. Czech.

Cite

Share

4

Cite

Share

New molecularly targeted therapies for glioblastoma multiforme.

Polivka J Jr, Polivka J, Rohan V, Topolcan O, Ferda J. Polivka J Jr, et al. Among authors: polivka j. Anticancer Res. 2012 Jul;32(7):2935-46. Anticancer Res. 2012. PMID: 22753758 Review.

Cite

Share

5

Cite

Share

Predictive and individualized management of stroke-success story in Czech Republic.

Polivka J, Polivka J Jr, Rohan V. Polivka J, et al. Among authors: polivka j jr. EPMA J. 2018 Oct 25;9(4):393-401. doi: 10.1007/s13167-018-0150-x. eCollection 2018 Dec. EPMA J. 2018. PMID: 30538791 Free PMC article. Review.

Cite

Share

6

Cite

Share

New treatment paradigm for patients with anaplastic oligodendroglial tumors.

Polivka J Jr, Polivka J, Rohan V, Topolcan O. Polivka J Jr, et al. Among authors: polivka j. Anticancer Res. 2014 Apr;34(4):1587-94. Anticancer Res. 2014. PMID: 24692686 Review.

Cite

Share

7

Cite

Share

BAI1 as a Prognostic Marker of Clear Cell Renal Cell Carcinoma (ccRCC).

Pesta M, Travnicek I, Kulda V, Windrichova J, Rezackova H, Houfkova K, Macanova T, Bendova B, Nestorova A, Hes O, Hora M, Topolcan O, Polivka J. Pesta M, et al. Among authors: polivka j. Anticancer Res. 2021 Sep;41(9):4463-4470. doi: 10.21873/anticanres.15255. Anticancer Res. 2021. PMID: 34475070

Cite

Share

8

Cite

Share

Personalized approach to primary and secondary prevention of ischemic stroke.

Polívka J, Rohan V, Sevčík P, Polívka J Jr. Polívka J, et al. Among authors: polivka j jr. EPMA J. 2014 Jun 4;5(1):9. doi: 10.1186/1878-5085-5-9. eCollection 2014. EPMA J. 2014. PMID: 24949113 Free PMC article. Review.

Cite

Share

9

Cite

Share

Caution, "normal" BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021.

Golubnitschaja O, Liskova A, Koklesova L, Samec M, Biringer K, Büsselberg D, Podbielska H, Kunin AA, Evsevyeva ME, Shapira N, Paul F, Erb C, Dietrich DE, Felbel D, Karabatsiakis A, Bubnov R, Polivka J, Polivka J Jr, Birkenbihl C, Fröhlich H, Hofmann-Apitius M, Kubatka P. Golubnitschaja O, et al. Among authors: polivka j jr, polivka j. EPMA J. 2021 Aug 17;12(3):243-264. doi: 10.1007/s13167-021-00251-4. eCollection 2021 Sep. EPMA J. 2021. PMID: 34422142 Free PMC article.

Cite

Share

10

Cite

Share

Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine.

Polivka J Jr, Altun I, Golubnitschaja O. Polivka J Jr, et al. EPMA J. 2018 Feb 8;9(1):1-13. doi: 10.1007/s13167-018-0129-7. eCollection 2018 Mar. EPMA J. 2018. PMID: 29515683 Free PMC article. Review.

Cite

Share